Global and China Human Platelet Lysate Market Insights, Forecast to 2027

Human platelet lysate (HPL) is a non-animal derived cell culture growth supplement obtained from blood platelets after freezing and thawing. HPL contains abundant growth factors and cytokines necessary for cell growth and proliferation. Platelet lysate can be used as a source of growth factors to replace bovine serum in cell culture medium. Replacing bovine serum with HPL allows expansion and clinical grade production of functional mesenchymal stromal cells by removing the risk of xenogeneic immune reactions and transmission of bovine prion and viral pathogens.

Market Analysis and Insights: Global and China Human Platelet Lysate Market
This report focuses on global and China Human Platelet Lysate market.
In 2020, the global Human Platelet Lysate market size was US$ 2515 million and it is expected to reach US$ 2913.3 million by the end of 2027, with a CAGR of 2.1% during 2021-2027. In China the Human Platelet Lysate market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Human Platelet Lysate Scope and Market Size
Human Platelet Lysate market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Human Platelet Lysate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Human Platelet Lysate market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type
Heparin
Heparin free

Segment by Application
Biopharmaceutical companies
Contract research organizations
Academic & research institutes
Pharmaceutical companies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Mill Creek Life Sciences
Merck & Co., Inc
STEMCELL Technologies Inc
AventaCell BioMedical
Compass Biomedical, Inc
Macopharma SA
Trinova Biochem GmbH
PL BioScience GmbH
Cook Regentec